SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-002286
Filing Date
2015-05-12
Accepted
2015-05-12 07:31:58
Documents
13
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tbuff_10q.htm 10-Q 640828
2 CERTIFICATIONS ex_311.htm EX-31.1 17441
3 CERTIFICATIONS ex_312.htm EX-31.2 17552
4 CERTIFICATIONS ex_321.htm EX-32.1 8374
5 CERTIFICATIONS ex_322.htm EX-32.2 8372
12 table1.jpg GRAPHIC 11269
13 table2.jpg GRAPHIC 16678
  Complete submission text file 0001354488-15-002286.txt   4064306

Data Files

Seq Description Document Type Size
6 tbuff-20150331.xml EX-101.INS 444658
7 tbuff-20150331.xsd EX-101.SCH 46450
8 tbuff-20150331_cal.xml EX-101.CAL 54203
9 tbuff-20150331_def.xml EX-101.DEF 90697
10 tbuff-20150331_lab.xml EX-101.LAB 263742
11 tbuff-20150331_pre.xml EX-101.PRE 194190
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 15852789
SIC: 2834 Pharmaceutical Preparations